Systematic biotechnological production of isoprenoid analogs with bespoke carbon skeletons.
90.0The authors present a yeast-based biocatalytic platform that systematically introduces extra carbons into diverse isoprenoid classes, enabling production of analogs with tailored properties. Proof-of-concept includes biosynthesis of ethyllinalool and cannabinoid analogs with enhanced receptor agonism, highlighting broad utility for fragrance and bioactive discovery.